TRIPALMITIN is a lipid of Glycerolipids (GL) class. Tripalmitin is associated with abnormalities such as Atherosclerosis, Hypoalphalipoproteinemias, Cystic Fibrosis, PARKINSON DISEASE, LATE-ONSET and Obesity. The involved functions are known as 5-(carboxyamino)imidazole ribonucleotide mutase activity, Certification, phosphatidylcholine-sterol O-acyltransferase activity, Regulation and Uptake. Tripalmitin often locates in Blood, Hepatic, Body tissue, Gastric mucosa and Biopsy sample. The associated genes with TRIPALMITIN are PON1 gene, very high density lipoproteins, THEMIS gene, HEPATIC PROTEIN and chylomicron remnant. The related lipids are Fatty Acids, Total cholesterol, Nonesterified Fatty Acids, Palmitates and tristearin.
To understand associated biological information of TRIPALMITIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
TRIPALMITIN is suspected in Atherosclerosis, Fatty Liver, Cystic Fibrosis, Hypoalphalipoproteinemias, PARKINSON DISEASE, LATE-ONSET, Obesity and other diseases in descending order of the highest number of associated sentences.
| Disease | Cross reference | Weighted score | Related literature |
|---|
We collected disease MeSH terms mapped to the references associated with TRIPALMITIN
| MeSH term | MeSH ID | Detail |
|---|---|---|
| Leishmaniasis, Visceral | D007898 | 13 associated lipids |
| Respiratory Distress Syndrome, Newborn | D012127 | 5 associated lipids |
| Cystic Fibrosis | D003550 | 65 associated lipids |
| Malabsorption Syndromes | D008286 | 16 associated lipids |
| HIV-Associated Lipodystrophy Syndrome | D039682 | 3 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
| Location | Cross reference | Weighted score | Related literatures |
|---|
| Function | Cross reference | Weighted score | Related literatures |
|---|
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
| Gene | Cross reference | Weighted score | Related literatures |
|---|
There are no associated biomedical information in the current reference collection.
| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Laiho KM et al. | Maldigestion and malabsorption of 13C labelled tripalmitin in gastrostomy-fed patients with cystic fibrosis. | 2004 | Clin Nutr | pmid:15158298 |
| Noiriel A et al. | Expression in yeast of a novel phospholipase A1 cDNA from Arabidopsis thaliana. | 2004 | Eur. J. Biochem. | pmid:15355352 |
| Gaudin K et al. | Adaptation of an evaporative light-scattering detector to micro and capillary liquid chromatography and response assessment. | 2004 | J Chromatogr A | pmid:15532554 |
| Venkateswarlu V and Manjunath K | Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. | 2004 | J Control Release | pmid:15023472 |
| Caboi F et al. | Effect of 1-butanol on the microstructure of lecithin/water/tripalmitin system. | 2005 | Chem. Phys. Lipids | pmid:15921975 |
| Moffitt JH et al. | Adverse physicochemical properties of tripalmitin in beta cells lead to morphological changes and lipotoxicity in vitro. | 2005 | Diabetologia | pmid:16094531 |
| Bresson S et al. | Raman spectroscopy investigation of various saturated monoacid triglycerides. | 2005 | Chem. Phys. Lipids | pmid:15784230 |
| Sekhar RV et al. | Severely dysregulated disposal of postprandial triacylglycerols exacerbates hypertriacylglycerolemia in HIV lipodystrophy syndrome. | 2005 | Am. J. Clin. Nutr. | pmid:15941894 |
| Bunjes H and Koch MH | Saturated phospholipids promote crystallization but slow down polymorphic transitions in triglyceride nanoparticles. | 2005 | J Control Release | pmid:16023752 |
| Manjunath K and Venkateswarlu V | Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration. | 2005 | J Control Release | pmid:16014318 |
| Garcia-Fuentes M et al. | New surface-modified lipid nanoparticles as delivery vehicles for salmon calcitonin. | 2005 | Int J Pharm | pmid:15885464 |
| Garcia-Fuentes M et al. | Design and characterization of a new drug nanocarrier made from solid-liquid lipid mixtures. | 2005 | J Colloid Interface Sci | pmid:15837476 |
| Sahin N et al. | Lipase-catalyzed acidolysis of tripalmitin with hazelnut oil fatty acids and stearic acid to produce human milk fat substitutes. | 2005 | J. Agric. Food Chem. | pmid:15998148 |
| Tosi A et al. | Tripalmitin-based cationic lipospheres: preparation, characterization and in Lab-on-a-chip applications. | 2006 | J Control Release | pmid:17718971 |
| Appel B et al. | Lipidic implants for controlled release of bioactive insulin: effects on cartilage engineered in vitro. | 2006 | Int J Pharm | pmid:16569486 |
| Elkharraz K et al. | Paclitaxel-loaded microparticles and implants for the treatment of brain cancer: preparation and physicochemical characterization. | 2006 | Int J Pharm | pmid:16490330 |
| Koennings S et al. | In vitro investigation of lipid implants as a controlled release system for interleukin-18. | 2006 | Int J Pharm | pmid:16513302 |
| Guse C et al. | Biocompatibility and erosion behavior of implants made of triglycerides and blends with cholesterol and phospholipids. | 2006 | Int J Pharm | pmid:16517106 |
| Srivastava A et al. | Candida rugosa lipase LIP1-catalyzed transesterification to produce human milk fat substitute. | 2006 | J. Agric. Food Chem. | pmid:16819932 |
| Manjunath K and Venkateswarlu V | Pharmacokinetics, tissue distribution and bioavailability of nitrendipine solid lipid nanoparticles after intravenous and intraduodenal administration. | 2006 | J Drug Target | pmid:17090399 |